Advertisement
Advertisement

From Research to Reality: Investing in HIV Prevention in a Challenging Landscape

September 2013

The HIV Vaccines & Microbicides Resource Tracking Working Group, comprised of AVAC, the International AIDS Vaccine Initiative (IAVI), and the Joint United Nations Programme on HIV/AIDS (UNAIDS), uses a comprehensive methodology to track annual research and development (R&D) investment trends in biomedical HIV prevention. Information collected in previous years has been used by the Working Group and others to monitor levels of effort, analyze the significance of investment trends and assess the impact of public policies aimed at accelerating scientific progress towards new prevention tools against HIV.


HIV Prevention R&D Global Investment by Region in 2012
HIV Prevention R&D Trial Participants by Region in 2012


Data compiled by the HIV Vaccines & Microbicides Resource Tracking Working Group.


Related Stories

AVAC's Take on HIV Prevention Research



This article was provided by AVAC: Global Advocacy for HIV Prevention. It is a part of the publication Px Wire. Visit AVAC's website to find out more about their activities and publications.
 

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Advertisement